Insulin detemir versus insulin glargine for type 2 diabetes mellitus: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Insulin Detemir Versus Insulin Glargine for Type 2 Diabetes Mellitus: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434760/0/images/google-play-badge.png. Accessed 27 April 2024.
Insulin detemir versus insulin glargine for type 2 diabetes mellitus: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434760/0/images/google-play-badge.png. Accessed April 27, 2024.
Insulin detemir versus insulin glargine for type 2 diabetes mellitus: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434760/0/images/google-play-badge.png
Insulin Detemir Versus Insulin Glargine for Type 2 Diabetes Mellitus: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434760/0/images/google-play-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Insulin detemir versus insulin glargine for type 2 diabetes mellitus: Cochrane systematic review
ID - 434760
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434760/0/images/google-play-badge.png
DB - Evidence Central
DP - Unbound Medicine
ER -